Why GLP-1 weight loss drugs don't make you weaker
Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
These drugs help you lose mostly fat, not muscle—even though you lose a little muscle, you become stronger relative to your weight and can run better.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 557 / 90
Evidence Score
Participants are randomly assigned to treatment or control groups, minimizing bias. Considered the gold standard for testing whether an intervention causes an effect.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
These drugs help you lose mostly fat, not muscle—even though you lose a little muscle, you become stronger relative to your weight and can run better.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 557 / 90
Evidence Score
Participants are randomly assigned to treatment or control groups, minimizing bias. Considered the gold standard for testing whether an intervention causes an effect.
Publication
Authors
Langer HT, Gilmore NK, Hayden CMT, Roux J, Bariohay B, Rouquet T, Awada M, Marcotorchino J, Bournot L, Nunn E, Titchenell PM, Liskiewicz D, Müller TD, Anyiam O, Atherton PJ, Idris I, Hentschel A, Roos A, Haritonow N, Norman K, Müller-Werdan U, Baar K
Related Content
Claims (6)
GLP-1 receptor agonists trigger changes in the body that occur even when weight loss is accounted for, suggesting these drugs have effects beyond reducing body weight.
In obese mice, using GLP-1 receptor agonists to lose weight does not cause more muscle loss during periods of inactivity than reducing calorie intake alone.
In obese mice, GLP-1 receptor agonists help maintain muscle function during weight loss by causing more fat to be lost than muscle, so the mice can run as well as lean mice even though their muscles get smaller.
In obese individuals with type 2 diabetes and in obese mice, GLP-1 receptor agonists cause weight loss primarily from fat tissue, while muscle mass is largely preserved. This results in a higher proportion of muscle relative to total body weight and maintained muscle strength, even though the total amount of muscle decreases slightly.
When people lose the same amount of weight through either GLP-1 receptor agonists or calorie restriction, the drugs cause different changes in muscle proteins related to energy production and protein breakdown compared to dieting alone.